½ÃÀ庸°í¼
»óÇ°ÄÚµå
1297129
¼¼°èÀÇ µðÁöÅÐ ´ç´¢º´ °ü¸® ½ÃÀå ±Ô¸ð : Á¦Ç° À¯Çüº°, ȯÀÚ À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(-2032³â)Digital Diabetes Management Market Size - By Product Type (Devices, Services), By Patient Type (Type 1, Type 2), By End-Use (Hospitals, Home Settings, Diagnostic Centers & Clinics) - Global Forecast to 2032 |
µðÁöÅÐ ´ç´¢º´ °ü¸® ¼¼°è ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö ºñ¾àÀûÀ¸·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ´ç´¢º´¿¡ ´ëÇÑ ÀÇ·áºñ ÁöÃâ Áõ°¡°¡ ¾÷°è ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¼¼°èÀÇ ´ç´¢º´ ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼¼°è ¸¹Àº Á¤ºÎ°¡ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀ» À§ÇÑ µðÁöÅÐ ´ç´¢º´ °ü¸® ¼Ö·ç¼Ç¿¡ ¸¹Àº ÅõÀÚ¸¦ ÇÏ°í ÀÖ½À´Ï´Ù. ½ÇÁ¦·Î ¸¹Àº Á¤ºÎ°¡ ÷´Ü ´ç´¢º´ °ü¸® ±â±â¿¡ À¯¸®ÇÑ »óȯ Á¤Ã¥À» ½ÃÇàÇÏ°í ÀÖÀ¸¸ç, ÀÌ´Â ¾÷°è »óȲÀ» ´õ¿í º¯È½Ãų °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ ºÐ¾ßÀÇ °Å´ë ±â¾÷µéÀº ÀÚ½ÅÀÇ ÀÔÁö¸¦ °ÈÇϱâ À§ÇØ Ã·´Ü Áø´Ü ±â±â °³¹ß¿¡ ÁÖ·ÂÇÏ°í ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå¿¡ »õ·Î¿î ¼ºÀåÀÇ ±æÀ» ¿¾îÁÖ°í ÀÖ½À´Ï´Ù.
Àüü µðÁöÅÐ ´ç´¢º´ °ü¸® ½ÃÀåÀº Á¦Ç°, ȯÀÚ, ÃÖÁ¾ ¿ëµµ ¹× Áö¿ªÀ» ±âÁØÀ¸·Î ºÐ·ùµË´Ï´Ù.
Á¦Ç°º°·Î´Â µðÁöÅÐ ´ç´¢º´ °ü¸® ±â±â ½ÃÀå °¡Ä¡´Â 2032³â±îÁö »ó´çÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´ç´¢º´ ¹ßº´·ü Áõ°¡¿Í ´ç´¢º´ °ü¸®¿¡ ´ëÇÑ °³ÀÎÈµÈ Á¢±Ù ¹æ½Ä¿¡ ´ëÇÑ »ç¶÷µéÀÇ ¼ºÇâÀÌ ±ÞÁõÇÏ¸é¼ µðÁöÅÐ ´ç´¢º´ °ü¸® ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ ÀåÄ¡´Â Æí¸®ÇÔ°ú »ç¿ë ÆíÀǼºÀ» Á¦°øÇÏ¿© °³ÀÎÀÌ Ç÷´ç ¼öÄ¡¸¦ ¸ð´ÏÅ͸µÇÏ°í ¸ÅÀÏ ´ç´¢º´À» ´õ ½±°Ô °ü¸® ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.
ȯÀÚº°·Î´Â 2023³âºÎÅÍ 2032³â±îÁö 19% ÀÌ»óÀÇ CAGR·Î Á¦1Çü ´ç´¢º´ ºÎ¹®ÀÇ »ê¾÷ ±Ô¸ð°¡ ¼ºÀåÇÒ °ÍÀ̸ç, Á¦1Çü ´ç´¢º´ÀÇ ±ÞÁõÀ¸·Î ÀÎÇØ µðÁöÅÐ ´ç´¢º´ °ü¸® ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. ½ÇÁ¦·Î Æ÷µµ´ç ¸ð´ÏÅ͸µ, ¿µ¾ç °ü¸®, Àν¶¸° ÀûÁ¤ ¹× Àν¶¸° Àü´ÞÀ» À§ÇÑ ¸ð¹ÙÀÏ ¾ÛÀº °Ç° ÃßÀûÀ» À§ÇØ Á¦ 1Çü ´ç´¢º´ ȯÀÚµé »çÀÌ¿¡¼ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ °èÃþÀº Àν¶¸°¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô±â ¶§¹®¿¡ Àν¶¸° Àü´Þ ÀåÄ¡ÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù.
ÃÖÁ¾ ¿ëµµ¿¡ µû¶ó Áø´Ü¼¾ÅÍ ¹× Ŭ¸®´Ð ºÎ¹®ÀÇ »ê¾÷ °¡Ä¡´Â 2032³â±îÁö »ó´çÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °í±Þ Àν¶¸° Àü´Þ ÀåÄ¡ÀÇ ³ôÀº °¡¿ë¼ºÀ¸·Î ÀÎÇØ Áø´Ü¼¾ÅÍ ¹× Ŭ¸®´Ð¿¡ ´ëÇÑ È¯ÀÚ ¹æ¹®ÀÌ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. ¸¹Àº Áø´Ü¼¾ÅÍ´Â ÇöÀç µðÁöÅÐ Ç÷§Æû ¹× ÀüÀÚ ÀÇ·á ±â·Ï ½Ã½ºÅÛ°úÀÇ ¿øÈ°ÇÑ ÅëÇÕÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÅëÇÕÀ» ÅëÇØ È¯ÀÚµéÀº °Ë»ç °á°ú¸¦ µðÁöÅзΠ¹Þ¾Æº¸°í, ½Ã°£¼øÀ¸·Î Ãß¼¼¸¦ È®ÀÎÇÏ°í, ÀÇ·á ¼ºñ½º Á¦°ø¾÷ü ¹× µðÁöÅÐ ´ç´¢º´ °ü¸® ¿ëµµ°ú µ¥ÀÌÅ͸¦ ½±°Ô °øÀ¯ÇÒ ¼ö ÀÖ½À´Ï´Ù.
Áö¿ªº°·Î º¸¸é, À¯·´ÀÇ µðÁöÅÐ ´ç´¢º´ °ü¸® ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 320¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ µîÀÇ ±¹°¡¿¡¼ ´ç´¢º´ ¹ßº´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ Áö¿ª¿¡¼ µðÁöÅÐ ´ç´¢º´ °ü¸® ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, F. Hoffmann-La Roche Ltd¿Í °°Àº ¾÷°è ¼±µµ ±â¾÷µéÀÌ ¾÷°è ÁöÀ§¸¦ À¯ÁöÇϱâ À§ÇØ Á¦Ç° Çõ½Å¿¡ ÁßÁ¡À» µÎ°í ÀÖ´Â °Íµµ ÀÌ Áö¿ªÀÇ ¼ºÀå¿¡ ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù.
Global Digital Diabetes Management Market size will expand exponentially through 2032. Growing healthcare expenditure towards diabetes is the key factor positively impacting the industry growth. Increasing global burden of diabetes has compelled many governments across the world to invest considerable amounts into digital diabetes management solutions for remote patient monitoring. In fact, many governments have also implemented favorable reimbursement policies for advanced diabetes management devices, which will further shape the industry landscape. Business behemoths in the space are emphasizing developing advanced diagnostic devices to strengthen their position, opening new growth avenues for the market.
The overall digital diabetes management market is categorized based on product, patient, end-use, and region.
In terms of product, digital diabetes management devices market value will depict considerable gains through 2032. Rising occurrence of diabetes, coupled with the surging inclination of people towards a personalized approach to diabetes care, has increased the demand for digital diabetes management devices. Additionally, these devices offer convenience and ease of use, making it simpler for individuals to monitor their blood glucose levels and manage their diabetes daily.
Based on patient, industry size from the type 1 segment will grow at over 19% CAGR from 2023 to 2032. Surging prevalence of type 1 diabetes has increased the adoption of digital diabetes management solutions. In fact, mobile apps for glucose monitoring, nutrition control, insulin titration, and insulin delivery have become increasingly popular among type 1 diabetic people for health tracking. Moreover, this demographic is highly dependent on insulin, which has increased the adoption of insulin-delivery devices.
Based on end-use, industry value from the diagnostic centers & clinics segment will witness significant gains through 2032. High availability of advanced insulin delivery devices has increased patient visits to diagnostic centers & clinics. Many diagnostic centers now offer seamless integration with digital platforms and electronic health record systems. This integration allows individuals to receive their test results digitally, view trends over time, and easily share data with their healthcare providers or digital diabetes management applications.
Regionally, Europe digital diabetes management market size will reach USD 32 billion by 2032. Growing incidence of diabetes in countries such as Germany, France, Italy, and Spain has increased the adoption of digital diabetes management solutions in the region. Moreover, regional expansion can also be attributed to the presence of leading industry giants such as F. Hoffmann-La Roche Ltd and others emphasizing product innovations to retain their industry standing.